141 related articles for article (PubMed ID: 21195709)
21. Reversal of cancer multidrug resistance by green tea polyphenols.
Mei Y; Qian F; Wei D; Liu J
J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
[TBL] [Abstract][Full Text] [Related]
22. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
Chan JY; Siu KP; Fung KP
Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806
[TBL] [Abstract][Full Text] [Related]
23. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
Dönmez Y; Gündüz U
Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
[TBL] [Abstract][Full Text] [Related]
24. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of NPM reverses multidrug resistance in human hepatoma cells via inhibition of P-glycoprotein expression.
Luo F; Li H; Liang J; Jia H; Li X; Xiao H; He X; He J; Tian Y; Zhao H
Mol Med Rep; 2017 Apr; 15(4):2360-2368. PubMed ID: 28259962
[TBL] [Abstract][Full Text] [Related]
26. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
27. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes.
Huesker M; Folmer Y; Schneider M; Fulda C; Blum HE; Hafkemeyer P
Hepatology; 2002 Oct; 36(4 Pt 1):874-84. PubMed ID: 12297834
[TBL] [Abstract][Full Text] [Related]
28. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
[TBL] [Abstract][Full Text] [Related]
29. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111
[TBL] [Abstract][Full Text] [Related]
31. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
33. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
34. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
35. Reversal of P-glycoprotein-mediated multidrug resistance in human hepatoma cells by hedyotiscone A, a compound isolated from Hedyotis corymbosa.
Yue GG; Kin-Ming Lee J; Cheng L; Chung-Lap Chan B; Jiang L; Fung KP; Leung PC; Bik-San Lau C
Xenobiotica; 2012 Jun; 42(6):562-70. PubMed ID: 22352391
[TBL] [Abstract][Full Text] [Related]
36. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
37. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA.
Li L; Xu J; Min T; Huang W
Eur J Pharmacol; 2006 Apr; 536(1-2):93-7. PubMed ID: 16564522
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic effects and in vitro reversal of multidrug resistance by therapeutic ultrasound in human hepatocarcinoma cell line (HepG2).
Shao ZY; Zhai BJ; Zhao CL; Hu K; Shen DM; Wu F
Ultrasonics; 2008 Aug; 48(4):297-302. PubMed ID: 18199465
[TBL] [Abstract][Full Text] [Related]
39. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic loss of CDH1 correlates with multidrug resistance in human hepatocellular carcinoma cells.
Jiang L; Chan JY; Fung KP
Biochem Biophys Res Commun; 2012 Jun; 422(4):739-44. PubMed ID: 22634315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
